Literature DB >> 10652677

[Surgical treatment of cardiovascular manifestations of Marfan's syndrome].

R Lange1, E Ebert.   

Abstract

Patients with Marfan's syndrome suffer mainly from the cardiovascular manifestations of the disease, in particular the acute dissection or rupture of the dilated aorta. Due to improved diagnostic and early surgical intervention the life expectancy of these patients could be considerably improved. However, rupture is still the most frequent and dissection the second frequent cause of death. Life threatening complications of aortic dissection are pericardial effusion, aortic insufficiency and malperfusion syndrome, due to obstruction of aortic branches. Dissection of the ascending aorta is treated by implantation of a valved conduit with reimplantation of the coronary arteries. Some surgeons favor the complete replacement of the ascending aorta with preservation of the aortic valve, although long-term results show some development of aortic insufficiency after this procedure. Based on the experience of the last years, most surgeons prefer the prophylactic replacement of the aorta in Marfan patients, i.e. before complications have occurred. A special treatment algorithm helps to define the indication for the operative treatment in different manifestations of the disease. The low mortality of the elective replacement of the ascending aorta in contrast to replacement in emergency cases speaks in favor of the early operative treatment. For the long-term prognosis of the patient a closed and continuous cardiologic surveillance is mandatory. The patient should be close to a center with the necessary diagnostic tools and with sufficient experience with the medical and surgical treatment, in order to further improve the life expectancy in the future.

Entities:  

Mesh:

Year:  1999        PMID: 10652677     DOI: 10.1007/bf03044488

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  30 in total

1.  Surgical management of mitral regurgitation associated with Marfan's syndrome.

Authors:  J F Fuzellier; S M Chauvaud; P Fornes; A J Berrebi; P S Lajos; P Bruneval; A F Carpentier
Journal:  Ann Thorac Surg       Date:  1998-07       Impact factor: 4.330

2.  The Marfan syndrome and the cardiovascular surgeon.

Authors:  V L Gott; J C Laschinger; D E Cameron; H C Dietz; P S Greene; A M Gillinov; R E Pyeritz; D E Alejo; K J Fleischer; G J Anhalt; C D Stone; V A McKusick
Journal:  Eur J Cardiothorac Surg       Date:  1996       Impact factor: 4.191

3.  Aortic root dilatation as a cause of isolated, severe aortic regurgitation. Prevalence, clinical and echocardiographic patterns, and relation to left ventricular hypertrophy and function.

Authors:  M J Roman; R B Devereux; N W Niles; C Hochreiter; P Kligfield; N Sato; M C Spitzer; J S Borer
Journal:  Ann Intern Med       Date:  1987-06       Impact factor: 25.391

Review 4.  An anatomic and physiologic approach to acquired heart disease. 8th annual meeting of the European Cardio-thoracic Association, The Hague, Netherlands, September 25-28, 1994.

Authors:  T E David
Journal:  Eur J Cardiothorac Surg       Date:  1995       Impact factor: 4.191

Review 5.  Marfan syndrome: current and future clinical and genetic management of cardiovascular manifestations.

Authors:  R E Pyeritz
Journal:  Semin Thorac Cardiovasc Surg       Date:  1993-01

6.  Genetic skeletal dysplasias in the Museum of Pathological Anatomy, Vienna.

Authors:  P Beighton; E Sujansky; B Patzak; K A Portele
Journal:  Am J Med Genet       Date:  1993-11-01

7.  Spinal cord protection using hypothermic cardiocirculatory arrest in extended repair of recoarctation and persistent hypoplastic aortic arch.

Authors:  R Lange; M Thielmann; K G Schmidt; R Bauernschmitt; H Jakob; B Hasper; H Ulmer; S Hagl
Journal:  Eur J Cardiothorac Surg       Date:  1997-04       Impact factor: 4.191

8.  Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome.

Authors:  K J Fleischer; H C Nousari; G J Anhalt; C D Stone; J C Laschinger
Journal:  Ann Thorac Surg       Date:  1997-04       Impact factor: 4.330

9.  An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta.

Authors:  T E David; C M Feindel
Journal:  J Thorac Cardiovasc Surg       Date:  1992-04       Impact factor: 5.209

10.  Impact of cardiovascular operation on survival in the Marfan patient.

Authors:  L G Svensson; E S Crawford; J S Coselli; H J Safi; K R Hess
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.